Asymmetry Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-53,583
Closed -$4.51M 33
2017
Q1
$4.51M Sell
53,583
-3,401
-6% -$272K 6.28% 8
2016
Q4
$4.19M Buy
56,984
+23,955
+73% +$1.78M 7.79% 5
2016
Q3
$2.65M Sell
33,029
-25,936
-44% -$2.08M 4.61% 10
2016
Q2
$4.64M Sell
58,965
-6,435
-10% -$484K 8.51% 3
2016
Q1
$4.71M Buy
+65,400
New +$4.95M 12.28% 2

Other funds holding LLY

Asymmetry Capital Management's LLY Position: Q2 2017 in Review

Asymmetry Capital Management sold out of Eli Lilly (LLY) in Q2 2017, closing a stake of 53,583 shares — an estimated $4.51M sold.

Asymmetry Capital Management first reported a position in LLY in Q1 2016 and held it in 5 quarters. The position peaked at $4.71M in Q1 2016. 1,246 funds tracked by Wall St. Rank hold LLY as of Q2 2017.

  • Asymmetry Capital Management reported no remaining Eli Lilly position as of Q2 2017 after selling out during the quarter.
  • Asymmetry Capital Management sold 53,583 Eli Lilly shares in Q2 2017, an estimated $4.51M.
  • Asymmetry Capital Management first reported a position in Eli Lilly in Q1 2016 and held it in 5 quarters.
  • Asymmetry Capital Management's Eli Lilly position peaked at $4.71M in Q1 2016.
  • 1,246 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2017.

Based on Asymmetry Capital Management's 13F filing for Q2 2017, filed 15 Aug 2017.